LivaNova PLC
NASDAQ:LIVN
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
43.38
64.15
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
LivaNova PLC
Net Margin
LivaNova PLC
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | UK |
| Market Cap | 2.5B USD |
| Net Margin |
2%
|
| Country | US |
| Market Cap | 199B USD |
| Net Margin |
14%
|
| Country | US |
| Market Cap | 191.3B USD |
| Net Margin |
29%
|
| Country | US |
| Market Cap | 141.3B USD |
| Net Margin |
16%
|
| Country | US |
| Market Cap | 134.2B USD |
| Net Margin |
11%
|
| Country | IE |
| Market Cap | 104.6B USD |
| Net Margin |
13%
|
| Country | US |
| Market Cap | 65.6B USD |
| Net Margin |
9%
|
| Country | DE |
| Market Cap | 58.1B EUR |
| Net Margin |
8%
|
| Country | US |
| Market Cap | 44.5B USD |
| Net Margin |
74%
|
| Country | CN |
| Market Cap | 310B CNY |
| Net Margin |
33%
|
| Country | US |
| Market Cap | 36.3B USD |
| Net Margin |
9%
|
LivaNova PLC
Glance View
LivaNova PLC is a dynamic player in the realm of medical technology, with its roots tracing back to the merger of two well-established entities, Sorin Group and Cyberonics, in 2015. This union was more than just a blending of operations; it marked the convergence of expertise in cardiac surgery and neuromodulation. Headquartered in London, LivaNova set out with a mission to innovate within the treatment space for life-critical conditions, making a name for itself in the healthcare sector by focusing on two principal areas: cardiovascular solutions and neuromodulation therapy. These areas aren't just buzzwords; they represent the backbone of the company’s operations, serving critical patient needs with a near-requirement for continuous technological advancement. LivaNova's revenue streams are primarily derived from its cutting-edge products used in life-sustaining procedures and therapeutic interventions. In cardiovascular solutions, the company excels with its offerings in heart-lung machines, used in cardiac surgeries, and heart valves, instrumental in treating heart valve disease. Meanwhile, their neuromodulation division stands at the forefront of treating refractory epilepsy and depression with devices that deliver electrical impulses to the vagus nerve. By continuously pushing the envelope on medical tech, LivaNova not only ensures reliable outcomes for patients but also maintains a robust portfolio that draws revenues from hospitals and clinics worldwide. This balance of innovative prowess and strategic product deployment is what enables LivaNova to mitigate risks and sustain its financial health amidst the volatile landscape of the global healthcare market.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on LivaNova PLC's most recent financial statements, the company has Net Margin of 1.9%.
You don't have any saved screeners yet
